Orgenesis Inc., a biotech company, focuses on cell and gene therapies in the United States. It operates through two segments: Octomera and Therapies. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed cell based POCare therapies that are processed and...
37 insider purchases on record · latest filing 2024-12-04.
Insiders have also filed 8 sale transactions at ORGS.